155. Tumor Necrosis In Vivo Caused by a Novel Combination of Sorafenib and Rapamycin: Targeting the RAS and Motor Pathways ION Hepatocellular Carcinoma — Pippa Newell (2008) | RDL Network
155. Tumor Necrosis In Vivo Caused by a Novel Combination of Sorafenib and Rapamycin: Targeting the RAS and Motor Pathways ION Hepatocellular Carcinoma
Philippa Newell, Augusto Villanueva, Judit Peix, Isabel Fiel, Swan N. Thung, Steven Yea, Sasan Roayaie, Myron Schwartz, Scott L. Friedman, Josep M. Llovet
Pippa Newell, Sara Toffanin, Augusto Villanueva, Derek Y. Chiang, Beatriz Mínguez, Laia Cabellos, Radoslav Savić, Yujin Hoshida, Kiat Hon Lim, Pedro Melgar‐Lesmes, Steven Yea, Judit Peix, Kemal Denız, Maria Isabel Fiel, Swan N. Thung, Clara Alsinet, Victoria Tovar, Vincenzo Mazzaferro, Jordi Bruix, Sasan Roayaie, Myron Schwartz, Scott L. Friedman, Josep M. Llovet
Josep M. Llovet, Philippe Merle, Karl Heinz Weiss, Thomas Yau, Paul J. Ross, Vincenzo Mazzaferro, Jean–Frédéric Blanc, Yuk Ting, Chia Jui Yen, Judit Kocsis, Su Pin Choo, Wattana Sukeepaisarnjaroen, René Gérolami, Jean‐François Dufour, Edward Gane, Baek‐Yeol Ryoo, Markus Peck‐Radosavljevic, Thông Dao, Winnie Yeo, Wisut Lamlertthon, Satawat Thongsawat, Michael Teufel, Heiko Krissel,
Victoria Tovar, Helena Cornellà, A. Moeni, Samuel J. Vidal, Yujin Hoshida, Daniela Sia, Judit Peix, Clara Alsinet, I.M. Quetglas, Manel Solé, Josep Domingo-Domènech, Augusto Villanueva, Josep M. Llovet
Discussion(0)
No comments yet. Be the first to comment.